Literature DB >> 15737764

Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone.

Jeremy John Wright1, Gerry O'driscoll.   

Abstract

A 59-year-old man developed a lower respiratory tract infection 10 years after orthotopic cardiac transplantation. He did not respond to broad-spectrum antibiotic and antifungal treatment. Parainfluenza virus type 3 was the causative organism, and he was successfully treated with intravenous ribavirin and methylprednisolone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737764     DOI: 10.1016/j.healun.2004.01.003

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

Review 1.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

2.  Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient.

Authors:  Takahiro Shima; Goichi Yoshimoto; Atsushi Nonami; Shuro Yoshida; Kenjiro Kamezaki; Hiromi Iwasaki; Katsuto Takenaka; Toshihiro Miyamoto; Naoki Harada; Takanori Teshima; Koichi Akashi; Koji Nagafuji
Journal:  Int J Hematol       Date:  2008-08-19       Impact factor: 2.490

3.  Current management of parainfluenza pneumonitis in immunocompromised patients: a review.

Authors:  Ann R Falsey
Journal:  Infect Drug Resist       Date:  2012-08-08       Impact factor: 4.003

Review 4.  Parainfluenza Virus Infection.

Authors:  Angela R Branche; Ann R Falsey
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

Review 5.  Respiratory viral infections in transplant and oncology patients.

Authors:  Deepali Kumar; Atul Humar
Journal:  Infect Dis Clin North Am       Date:  2010-06       Impact factor: 5.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.